Importer of Controlled Substances Application: Cambrex High Point, Inc., 44406 [2021-17185]
Download as PDF
<![CDATA[
44406
Federal Register / Vol. 86, No. 153 / Thursday, August 12, 2021 / Notices
Registered bulk manufacturers of
the affected basic class(es), and
applicants therefore, may file written
comments on or objections to the
issuance of the proposed registration on
or before September 13, 2021. Such
persons may also file a written request
for a hearing on the application on or
before September 13, 2021.
DATES:
Written comments should
be sent to: Drug Enforcement
Administration, Attention: DEA Federal
Register Representative/DPW, 8701
Morrissette Drive, Springfield, Virginia
22152. All requests for a hearing must
be sent to: Drug Enforcement
Administration, Attn: Administrator,
8701 Morrissette Drive, Springfield,
Virginia 22152. All request for a hearing
should also be sent to: (1) Drug
Enforcement Administration, Attn:
Hearing Clerk/OALJ, 8701 Morrissette
Drive, Springfield, Virginia 22152; and
(2) Drug Enforcement Administration,
Attn: DEA Federal Register
Representative/DPW, 8701 Morrissette
Drive, Springfield, Virginia 22152.
ADDRESSES:
In
accordance with 21 CFR 1301.34(a), this
is notice that on May 7, 2021, Globyz
Pharma, LLC., 2101 Market Street, Suite
5, Upper Chichester, Pennsylvania
19061–4001, applied to be registered as
an importer of the following basic
class(es) of controlled substance(s):
SUPPLEMENTARY INFORMATION:
Drug
code
Controlled substance
Lisdexamfetamine .........
I
1205
Schedule
II
lotter on DSK11XQN23PROD with NOTICES1
The company plans to import finished
dosage unit products of
Lisdexamfetamine for the one time need
of analytical testing. No other activity
for this drug codes is authorized for this
registration.
Approval of permit applications will
occur only when the registrant’s
business activity is consistent with what
is authorized under 21 U.S.C. 952(a)(2).
Authorization will not extend to the
import of Food and Drug
Administration-approved or nonapproved finished dosage forms for
commercial sale.
Brian S. Besser,
Acting Assistant Administrator.
Drug Enforcement Administration
[Docket No. DEA–881]
Drug Enforcement Administration
Notice of application.
[Docket No. DEA–882]
Cambrex High Point, Inc., has
applied to be registered as an importer
of basic class(es) of controlled
substance(s). Refer to Supplemental
Information listed below for further
drug information.
Importer of Controlled Substances
Application: MP Pharma Services
Registered bulk manufacturers of
the affected basic class(es), and
applicants therefore, may file written
comments on or objections to the
issuance of the proposed registration on
or before September 13, 2021. Such
persons may also file a written request
for a hearing on the application on or
before September 13, 2021.
SUMMARY:
SUMMARY:
DATES:
Written comments should
be sent to: Drug Enforcement
Administration, Attention: DEA Federal
Register Representative/DPW, 8701
Morrissette Drive, Springfield, Virginia
22152. All requests for a hearing must
be sent to: Drug Enforcement
Administration, Attn: Administrator,
8701 Morrissette Drive, Springfield,
Virginia 22152. All requests for a
hearing should also be sent to: (1) Drug
Enforcement Administration, Attn:
Hearing Clerk/OALJ, 8701 Morrissette
Drive, Springfield, Virginia 22152; and
(2) Drug Enforcement Administration,
Attn: DEA Federal Register
Representative/DPW, 8701 Morrissette
Drive, Springfield, Virginia 22152.
ADDRESSES:
In
accordance with 21 CFR 1301.34(a), this
is notice that on July 9, 2021, Cambrex
High Point, Inc., 4180 Mendenhall Oaks
Parkway, High Point, North Carolina
27265–8017, applied to renew as an
importer of the following basic class(es)
of controlled substance(s):
SUPPLEMENTARY INFORMATION:
Drug
code
Controlled substance
Poppy Straw Concentrate.
Schedule
9670
I
II
I
The company plans to import Poppy
Straw Concentrate to develop its own
portfolio of generic products. Approval
of permit applications will occur only
when the registrant’s business activity is
BILLING CODE P
20:11 Aug 11, 2021
Jkt 253001
BILLING CODE P
DEPARTMENT OF JUSTICE
Drug Enforcement
Administration, Justice.
AGENCY:
ACTION:
Brian S. Besser,
Acting Assistant Administrator.
[FR Doc. 2021–17185 Filed 8–11–21; 8:45 am]
Importer of Controlled Substances
Application: Cambrex High Point, Inc.
[FR Doc. 2021–17181 Filed 8–11–21; 8:45 am]
VerDate Sep<11>2014
consistent with what is authorized
under 21 U.S.C. 952(a)(2).
DEPARTMENT OF JUSTICE
PO 00000
Frm 00075
Fmt 4703
Sfmt 4703
Drug Enforcement
Administration, Justice.
ACTION: Notice of application.
AGENCY:
MP Pharma Services has
applied to be registered as an importer
of basic class(es) of controlled
substance(s). Refer to Supplemental
Information listed below for further
drug information.
DATES: Registered bulk manufacturers of
the affected basic class(es), and
applicants therefore, may file written
comments on or objections to the
issuance of the proposed registration on
or before September 13, 2021. Such
persons may also file a written request
for a hearing on the application on or
before September 13, 2021.
ADDRESSES: Written comments should
be sent to: Drug Enforcement
Administration, Attention: DEA Federal
Register Representative/DPW, 8701
Morrissette Drive, Springfield, Virginia
22152. All requests for a hearing must
be sent to: Drug Enforcement
Administration, Attn: Administrator,
8701 Morrissette Drive, Springfield,
Virginia 22152. All request for a hearing
should also be sent to: (1) Drug
Enforcement Administration, Attn:
Hearing Clerk/OALJ, 8701 Morrissette
Drive, Springfield, Virginia 22152; and
(2) Drug Enforcement Administration,
Attn: DEA Federal Register
Representative/DPW, 8701 Morrissette
Drive, Springfield, Virginia 22152.
SUPPLEMENTARY INFORMATION: In
accordance with 21 CFR 1301.34(a), this
is notice that on June 30, 2021, MP
Pharma Services, 4222 Emperor
Boulevard, Suite 320, Durham, North
Carolina 27703–9455, applied to be
registered as an importer of the
following basic class(es) of controlled
substance(s):
Drug
code
Controlled substance
5-Methoxy-N-NDimethyltryptamine.
E:\FR\FM\12AUN1.SGM
12AUN1
Schedule
7431
I
I
I
]]>Agencies
[Federal Register Volume 86, Number 153 (Thursday, August 12, 2021)]
[Notices]
[Page 44406]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2021-17185]
-----------------------------------------------------------------------
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
[Docket No. DEA-881]
Importer of Controlled Substances Application: Cambrex High
Point, Inc.
AGENCY: Drug Enforcement Administration, Justice.
ACTION: Notice of application.
-----------------------------------------------------------------------
SUMMARY: Cambrex High Point, Inc., has applied to be registered as an
importer of basic class(es) of controlled substance(s). Refer to
Supplemental Information listed below for further drug information.
DATES: Registered bulk manufacturers of the affected basic class(es),
and applicants therefore, may file written comments on or objections to
the issuance of the proposed registration on or before September 13,
2021. Such persons may also file a written request for a hearing on the
application on or before September 13, 2021.
ADDRESSES: Written comments should be sent to: Drug Enforcement
Administration, Attention: DEA Federal Register Representative/DPW,
8701 Morrissette Drive, Springfield, Virginia 22152. All requests for a
hearing must be sent to: Drug Enforcement Administration, Attn:
Administrator, 8701 Morrissette Drive, Springfield, Virginia 22152. All
requests for a hearing should also be sent to: (1) Drug Enforcement
Administration, Attn: Hearing Clerk/OALJ, 8701 Morrissette Drive,
Springfield, Virginia 22152; and (2) Drug Enforcement Administration,
Attn: DEA Federal Register Representative/DPW, 8701 Morrissette Drive,
Springfield, Virginia 22152.
SUPPLEMENTARY INFORMATION: In accordance with 21 CFR 1301.34(a), this
is notice that on July 9, 2021, Cambrex High Point, Inc., 4180
Mendenhall Oaks Parkway, High Point, North Carolina 27265-8017, applied
to renew as an importer of the following basic class(es) of controlled
substance(s):
------------------------------------------------------------------------
Drug
Controlled substance code Schedule
------------------------------------------------------------------------
Poppy Straw Concentrate................ 9670 II
------------------------------------------------------------------------
The company plans to import Poppy Straw Concentrate to develop its
own portfolio of generic products. Approval of permit applications will
occur only when the registrant's business activity is consistent with
what is authorized under 21 U.S.C. 952(a)(2).
Brian S. Besser,
Acting Assistant Administrator.
[FR Doc. 2021-17185 Filed 8-11-21; 8:45 am]
BILLING CODE P
